How Long Does a PRP Injection Take to Work?

Most people who receive a PRP injection for a musculoskeletal problem begin noticing meaningful improvement somewhere between four and twelve weeks after the procedure, though the specific timeline depends heavily on what is being treated. A knee with mild arthritis may feel better within six weeks; a stubborn tendon problem like tennis elbow or plantar fasciitis often takes two to three months before the gains become clear. The biology behind this delay is worth understanding, because it explains why PRP feels like a slow burn compared to something like a cortisone shot, and why that slower onset often comes with a longer-lasting payoff.

What Happens in the First Hours and Days

PRP works by concentrating your own platelets and injecting them into damaged tissue, where they release a burst of growth factors and signaling molecules that kick-start repair. That burst is fast. Laboratory studies show that roughly 30% of a PRP preparation’s bioactive content is released within the first hour after activation, with a steady release continuing until about 70% has been delivered over the following days.¹ In the first 15 to 60 minutes, PRP releases significantly more growth factors than other platelet-based preparations, giving it a front-loaded biological punch.²

What you actually feel in those first hours, though, is not healing but inflammation. Injecting concentrated platelets and white blood cells into tissue triggers a local inflammatory reaction that typically peaks between 6 and 24 hours after the injection and fades within about 48 hours.³ This is the “flare” that many patients describe: the injection site gets sore, sometimes more painful than before the shot. It can be discouraging if you do not expect it, but it is part of the intended process. The growth factors released during this early phase ramp up inflammatory signaling molecules and activate repair pathways in the surrounding tissue.⁴

Knee Osteoarthritis

Knee arthritis is the most studied application for PRP injections, and the timeline data here is relatively solid. A systematic review looking specifically at how long different knee injections take to reach peak pain relief found that leukocyte-rich PRP reaches its best pain control at about four to six weeks, while leukocyte-poor PRP takes closer to three months.⁵ That same review found that leukocyte-rich PRP had the most prolonged pain relief of any injection type at final follow-up, while leukocyte-poor PRP showed the best functional scores a full year after treatment.

A prospective cohort study measured improvements in pain and function scores at six weeks and found they persisted through 24 weeks, particularly in younger patients and those with milder disease.⁶ Another trial comparing PRP to hyaluronic acid found that both groups improved within the first month, but the hyaluronic acid group’s gains faded back to baseline by six months and continued declining, while the PRP group maintained significantly better scores all the way through one year.⁷

The practical takeaway for knee arthritis: expect the first month to be a waiting game, with the biggest gains typically arriving between weeks four and twelve. If you are going to respond to PRP, you should know it by month three.

Does PRP Actually Rebuild Cartilage?

One question patients frequently have is whether PRP can reverse structural damage in the joint, not just reduce pain. The evidence here is honest but humbling. A study using 3D MRI to map cartilage thickness six months after PRP injection found that most knee regions showed no meaningful change; only about 14% to 43% of patients showed any measurable cartilage thickening, depending on the region of the knee examined.⁸ Another study that followed patients for a full year after PRP found no change per knee compartment on MRI in at least 73% of cases.⁹ A separate trial evaluating both clinical outcomes and structural MRI findings at six months found that while pain and function scores improved significantly, there were no significant differences in MRI grading of cartilage defects, bone marrow lesions, or effusion between baseline and follow-up.¹⁰

In other words, PRP can make your knee feel and function better, but it probably is not regrowing cartilage in any clinically meaningful way. The benefit appears to come from reducing inflammation and modifying the joint environment rather than rebuilding lost tissue. That matters for managing expectations: PRP is not reversing your arthritis, but it can buy you significant symptom relief for months to a year or more.

Tendon Problems and Plantar Fasciitis

Tendons are notoriously slow to heal, and PRP follows that same timeline. For plantar fasciitis, one trial tracked patients for two years and found that PRP-treated feet improved from a functional score of 37 at baseline to 95 by three months, holding steady through two years with a final score of 92.¹¹ A randomized trial comparing PRP to cortisone and placebo for plantar fasciitis captured an interesting dynamic: corticosteroid injections produced better short-term relief, but by the 18-month mark PRP was significantly superior, with pain scores dropping from about 8 out of 10 at baseline to roughly 2 in the PRP group versus nearly 4 in the cortisone group.¹²

For tennis elbow (lateral epicondylitis), the pattern is similar. A systematic review found that corticosteroid injections gave rapid improvement peaking around six to eight weeks, followed by symptom recurrence, while PRP showed slower but ongoing improvements lasting up to one or even two years.¹³ Rotator cuff injuries follow a roughly comparable trajectory: a meta-analysis found PRP was somewhat better for pain in the short term and increasingly better for function over time, with the functional difference widening after 24 weeks.¹⁴

If you are getting PRP for a tendon condition, the realistic window is roughly two to three months before you can judge whether it worked, with continued improvement possible over six months or longer.

The Cortisone Comparison

One of the most common questions people ask after learning about PRP’s slow timeline is whether they would be better off just getting cortisone instead. The answer is a consistent “it depends on your time horizon.” A trial in knee osteoarthritis patients found that cortisone produced significant improvement at two months, but by six months several pain and stiffness scores had crept back toward baseline. PRP groups, whether receiving one injection or three, maintained significantly better movement pain and overall function scores at six months.¹⁵

This crossover pattern, where cortisone starts strong and fades while PRP starts slow and holds, shows up across conditions. If you need relief for a specific event in the next few weeks, cortisone has the edge. If you are looking for something that will still be helping in six months, PRP has the better track record.

Acute Muscle Injuries

PRP works on a faster clock for acute muscle tears than for degenerative conditions, which makes intuitive sense: a fresh injury already has an active healing process that PRP can amplify. A randomized trial of athletes with acute muscle tears found that the PRP group returned to play in an average of about 21 days compared to 25 days for controls.¹⁶ A meta-analysis of PRP for hamstring injuries found a somewhat larger gap, with PRP-treated athletes returning roughly nine days sooner on average, though the data varied substantially between studies.¹⁷ Case series in the sports medicine literature also report imaging evidence of faster healing and less swelling.¹⁸

One thing the meta-analysis also noted: reinjury rates were essentially the same whether or not athletes received PRP, at about 15% to 16%. So PRP may get you back faster, but it does not appear to make the healed muscle more durable.

Hair Loss

PRP for androgenetic alopecia (pattern hair loss) operates on an entirely different timeline from joint or tendon treatments, because hair follicle cycling is slow. A randomized controlled trial measured hair density at baseline and after a series of PRP sessions, finding a significant increase from about 151 hairs per square centimeter to roughly 171 hairs per square centimeter by the final assessment.¹⁹ A separate double-blinded study found that both activated and non-activated PRP increased hair density, with the peak gains measured at around 12 weeks after the last treatment session and gradual tapering over the following months.²⁰ Another randomized trial evaluating different platelet concentrations found that both lower and higher cell-count PRP produced increases in hair density and follicle diameter by six months.²¹

For hair restoration, the realistic expectation is three to six months of patience after completing a treatment course, and the results tend to fade gradually without maintenance sessions.

What Influences How Quickly PRP Works

Not everyone responds to PRP on the same schedule, and a few factors can meaningfully shift the timeline.

Disease severity matters, especially in joint conditions. One study found that increasing degeneration on imaging shortened how long PRP benefits lasted and reduced the overall magnitude of improvement. There was also a statistically significant relationship between older age and reduced PRP efficacy.²² Earlier-stage arthritis and younger patients tend to respond more robustly and more quickly. A skin study, however, found no significant difference in treatment response between patients over and under 40 when PRP was used for dermal rejuvenation, suggesting that the age effect may be specific to degenerative joint disease rather than a universal PRP limitation.²³

The number of injections also plays a role. A randomized trial gave some knee osteoarthritis patients a second cycle of three PRP injections at the one-year mark and found that those patients had significantly better outcomes at 18 months compared to those who received only one cycle.²⁴ Systematic reviews for knee OA have echoed this, noting that PRP efficacy increases after multiple injections and that re-intervention rates over time are lower in PRP groups compared to hyaluronic acid.²⁵

Combining PRP with hyaluronic acid may also improve outcomes. A meta-analysis found that injecting both together produced better pain and function scores than either alone.²⁶

NSAIDs and PRP Timing

If you take anti-inflammatory medications like ibuprofen or naproxen, your doctor will likely ask you to stop them before and after the injection, which can affect your comfort during the waiting period. The concern is that NSAIDs interfere with platelet function, potentially undermining the whole point of the treatment. A review looking at specific drugs found that ibuprofen and diclofenac no longer inhibited platelet activity after about 6 to 12 hours, naproxen required 24 to 48 hours of deferral due to its longer half-life, and acetaminophen did not inhibit platelet function even at somewhat higher-than-normal doses.²⁷

Post-injection NSAID restrictions are even more common. A systematic review of protocols for tendon PRP treatments found that while only about 20% of studies reported restricting NSAIDs before injection, 56% restricted them afterward, with a typical restriction lasting more than two weeks.²⁸ This is worth knowing because the post-injection flare during the first 48 hours can be uncomfortable, and your main tool for managing it (over-the-counter anti-inflammatories) may be off limits. Ice and acetaminophen are generally the recommended alternatives during that window.

Leukocyte Content and Activation Method

Not all PRP preparations are the same, and the differences can influence how quickly the treatment kicks in. One major variable is whether the preparation includes white blood cells (leukocyte-rich) or filters them out (leukocyte-poor). As noted in the knee osteoarthritis data, leukocyte-rich PRP tends to reach peak pain relief sooner, around four to six weeks, while leukocyte-poor PRP peaks around three months but may show better functional scores at one year.⁵ In a wound-healing model, leukocyte-rich PRP produced a stronger early inflammatory response and better initial healing rates, while both types ultimately outperformed controls.²⁹

How platelets are activated before injection also changes the release curve. When PRP is activated with thrombin, growth factors flood out immediately and then plateau. When calcium chloride alone is used, the release is slower and more sustained, with concentrations still rising at a week.³⁰ Other activation methods, including light-based activation, have produced sustained growth factor release lasting as long as 28 days in laboratory settings.³¹ Different activators shift the balance between speed and duration of action, with thrombin-based methods producing a sharp spike and calcium-based methods delivering a more gradual drip. The choice between these methods varies by clinic and condition, and there is no universal consensus on which is best for a given problem.³²

The Placebo Question

Any honest discussion of PRP timelines has to address a well-designed trial that muddied the waters. The RESTORE trial, a large randomized study, injected PRP into one group of knee osteoarthritis patients and a saline placebo into another. Both groups improved substantially, with pain scores dropping by roughly 32% to 37%, but the difference between the two groups was not statistically significant and fell outside the range considered clinically meaningful.³³

This does not necessarily mean PRP “does not work” for knees, but it does raise the possibility that some of the improvement people experience is driven by the injection procedure itself, the natural history of symptoms that fluctuate over time, or the placebo effect. It also highlights a methodological challenge: many of the studies showing PRP benefits compared it to hyaluronic acid or cortisone rather than to a true placebo. When the comparator is another active treatment, both groups may be improving partly for non-specific reasons, making PRP look effective by comparison without proving it does more than a sham injection.

For someone weighing whether to get PRP, the RESTORE trial is a reminder that the most rigorous evidence for knee osteoarthritis is still contested, and that the impressive timelines reported in other studies may overstate the specific contribution of the platelets themselves. For tendon conditions and muscle injuries, the placebo-controlled data is thinner but generally more favorable to PRP, though the same caveats about study quality apply.

Why Clinics Vary So Much in What They Promise

If you shop around for PRP, you will encounter wildly different claims about how fast it works, ranging from “you’ll feel better in days” to “give it six months.” Part of this is the difference between conditions: a muscle tear and a degenerative knee live in completely different biological worlds. But another part is that PRP itself is not a single standardized product. The platelet concentration, leukocyte content, activation method, injection volume, number of injections, and use of image guidance all vary between clinics and even between individual preparations at the same clinic. Two patients both told they received “PRP for their knee” may have received biologically very different injections.

This lack of standardization is the single biggest problem in the PRP field. It makes it difficult to compare studies, hard to replicate results, and nearly impossible for patients to evaluate competing claims. When a clinic tells you PRP will work in two weeks, ask what evidence they are basing that on and for what condition. When another clinic says three months, they may be using a completely different protocol. Neither is necessarily wrong; they may just be talking about different products.